Pharmaceutical and clinical implications of proton pump inhibitors with dual antiplatelet therapies: a systematic review
Jacob J. Gries(Geisinger Medical Center), Chayakrit Krittanawong(NYU Langone Health), Umair Khalid(Michael E. DeBakey VA Medical Center), Carl J. Lavie(University of New Orleans), Yochai Birnbaum(Baylor College of Medicine), Hafeez Ul Hassan Virk(University Hospitals of Cleveland), Dirk Sibbing(Ludwig-Maximilians-Universität München), George Triadafilopoulos(Stanford University), Hani Jneid, Glenn N. Levine(American College of Cardiology)
Cited by 6
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2011|2.2k